Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Prostate Cancer

Free Subscription Articles published in Radiology Retrieve available abstracts of 61 articles: HTML format

Single Articles

May 2024
1. LIN Y, Yilmaz EC, Belue MJ, Harmon SA, et al
   Evaluation of a Cascaded Deep Learning-based Algorithm for Prostate Lesion Detection at Biparametric MRI.
   Radiology. 2024;311:e230750.
   PubMed     Abstract available
   
   
   April 2024
2. JEWELL K, Hofman MS, Ong JSL, Levy S, et al
   Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy.
   Radiology. 2024;311:e231703.
   PubMed     Abstract available
   
   
   March 2024
3. WOODRUM DA
   Less Is More: MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer.
   Radiology. 2024;310:e240258.
   PubMed    
   
   
   
4. GHAI S, Finelli A, Corr K, Lajkosz K, et al
   MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial.
   Radiology. 2024;310:e231473.
   PubMed     Abstract available
   
   
   December 2023
5. MURAD V, Glicksman RM, Berlin A, Santiago A, et al
   Association of PSMA PET-derived Parameters and Outcomes of Patients Treated for Oligorecurrent Prostate Cancer.
   Radiology. 2023;309:e231407.
   PubMed     Abstract available
   
   
   
6. ALABOUSI M, Ghai S, Haider MA
   MRI-guided Minimally Invasive Focal Therapies for Prostate Cancer.
   Radiology. 2023;309:e230431.
   PubMed     Abstract available
   
   
   
7. CIVELEK AC
   PSMA PET Parameters for Predicting Outcomes in Patients with Prostate Cancer.
   Radiology. 2023;309:e233023.
   PubMed    
   
   
   November 2023
8. TAKAHASHI T
   Prebiopsy Risk Calculators, Such as MRI and Prostate Cancer Screening, Are Early-phase Clinical Trials.
   Radiology. 2023;309:e231177.
   PubMed    
   
   
   
9. AGUIRRE DA, Cardona Ortegon JD
   Unlocking the Benefits of Multiparametric MRI for Predicting Prostate Cancer Recurrence.
   Radiology. 2023;309:e232819.
   PubMed    
   
   
   
10. LUZZAGO S, Colombo A, Mistretta FA, Alessi S, et al
    Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical Prostatectomy.
    Radiology. 2023;309:e223349.
    PubMed     Abstract available
    
    
    September 2023
11. BISCHOFF LM, Peeters JM, Weinhold L, Krausewitz P, et al
    Deep Learning Super-Resolution Reconstruction for Fast and Motion-Robust T2-weighted Prostate MRI.
    Radiology. 2023;308:e230427.
    PubMed     Abstract available
    
    
    July 2023
12. GAFITA A, Djaileb L, Rauscher I, Fendler WP, et al
    Response Evaluation Criteria in PSMA PET/CT (RECIP 1.0) in Metastatic Castration-resistant Prostate Cancer.
    Radiology. 2023;308:e222148.
    PubMed     Abstract available
    
    
    
13. WEI C, Szewczyk-Bieda M, Bates AS, Donnan PT, et al
    Multicenter Randomized Trial Assessing MRI and Image-guided Biopsy for Suspected Prostate Cancer: The MULTIPROS Study.
    Radiology. 2023;308:e221428.
    PubMed     Abstract available
    
    
    June 2023
14. PADHANI AR, Schoots IG
    Imaging-based Diagnostic and Therapeutic Strategies for Prostate Cancer in the Coming Decades.
    Radiology. 2023;307:e222990.
    PubMed    
    
    
    
15. TURKBEY B, Purysko AS
    PI-RADS: Where Next?
    Radiology. 2023;307:e223128.
    PubMed     Abstract available
    
    
    May 2023
16. YILMAZ EC, Shih JH, Belue MJ, Harmon SA, et al
    Prospective Evaluation of PI-RADS Version 2.1 for Prostate Cancer Detection and Investigation of Multiparametric MRI-derived Markers.
    Radiology. 2023 May 2:221309. doi: 10.1148/radiol.221309.
    PubMed     Abstract available
    
    
    
17. GOH V
    PI-RADS and Multiparametric MRI: The Shape of Things to Come for Prostate Cancer.
    Radiology. 2023 May 2:230643. doi: 10.1148/radiol.230643.
    PubMed    
    
    
    April 2023
18. SEIFERT R, Rasul S, Seitzer K, Eveslage M, et al
    A Prognostic Risk Score for Prostate Cancer Based on PSMA PET-derived Organ-specific Tumor Volumes.
    Radiology. 2023 Apr 18:222010. doi: 10.1148/radiol.222010.
    PubMed     Abstract available
    
    
    
19. CIVELEK AC
    Reawakening of Nuclear Medicine through Molecular Imaging: Quantitative Theranostics and PSMA PET.
    Radiology. 2023 Apr 18:230627. doi: 10.1148/radiol.230627.
    PubMed    
    
    
    
20. HAMM CA, Baumgartner GL, Biessmann F, Beetz NL, et al
    Interactive Explainable Deep Learning Model Informs Prostate Cancer Diagnosis at MRI.
    Radiology. 2023 Apr 11:222276. doi: 10.1148/radiol.222276.
    PubMed     Abstract available
    
    
    
21. CHAPIRO J
    Explainable AI for Prostate MRI: Don't Trust, Verify.
    Radiology. 2023 Apr 11:230574. doi: 10.1148/radiol.230574.
    PubMed    
    
    
    February 2023
22. SCIALPI M, Martorana E, Scalera GB, Scialpi P, et al
    Apparent Diffusion Coefficient and Lesion Volume to Detect Prostate Cancer.
    Radiology. 2023 Feb 28:222177. doi: 10.1148/radiol.222177.
    PubMed    
    
    
    December 2022
23. STAVRINIDES V, Norris JM, Karapanagiotis S, Giganti F, et al
    Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial.
    Radiology. 2022 Dec 13:220762. doi: 10.1148/radiol.220762.
    PubMed     Abstract available
    
    
    September 2022
24. PARIHAR AS, Hofman MS, Iravani A
    (177)Lu-Prostate-specific Membrane Antigen Radioligand Therapy in Patients with Metastatic Castration-resistant Prostate Cancer.
    Radiology. 2022 Sep 20:220859. doi: 10.1148/radiol.220859.
    PubMed     Abstract available
    
    
    August 2022
25. GOH V
    Tumor Physiology and Clinically Significant Prostate Cancer Detection.
    Radiology. 2022 Aug 16:221798. doi: 10.1148/radiol.221798.
    PubMed    
    
    
    
26. TAVAKOLI AA, Hielscher T, Badura P, Gortz M, et al
    Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer.
    Radiology. 2022 Aug 16:212692. doi: 10.1148/radiol.212692.
    PubMed     Abstract available
    
    
    
27. SINGH S, Rogers H, Kanber B, Clemente J, et al
    Avoiding Unnecessary Biopsy after Multiparametric Prostate MRI with VERDICT Analysis: The INNOVATE Study.
    Radiology. 2022 Aug 2:212536. doi: 10.1148/radiol.212536.
    PubMed     Abstract available
    
    
    July 2022
28. LEE GH, Chatterjee A, Karademir I, Engelmann R, et al
    Comparing Radiologist Performance in Diagnosing Clinically Significant Prostate Cancer with Multiparametric versus Hybrid Multidimensional MRI.
    Radiology. 2022 Jul 26:211895. doi: 10.1148/radiol.211895.
    PubMed     Abstract available
    
    
    
29. TURKBEY B
    Hybrid Multidimensional Prostate MRI: A Quantitative Step in the Right Direction.
    Radiology. 2022 Jul 26:221452. doi: 10.1148/radiol.221452.
    PubMed    
    
    
    
30. ZUKOTYNSKI KA, Kuo PH
    (18)F-DCFPyL PET/CT in Men with Prostate Cancer.
    Radiology. 2022 Jul 19:221536. doi: 10.1148/radiol.221536.
    PubMed    
    
    
    
31. ULANER GA, Thomsen B, Bassett J, Torrey R, et al
    (18)F-DCFPyL PET/CT for Initially Diagnosed and Biochemically Recurrent Prostate Cancer: Prospective Trial with Pathologic Confirmation.
    Radiology. 2022 Jul 19:220218. doi: 10.1148/radiol.220218.
    PubMed     Abstract available
    
    
    
32. GHAI S, Perlis N, Atallah C, Jokhu S, et al
    Comparison of Micro-US and Multiparametric MRI for Prostate Cancer Detection in Biopsy-Naive Men.
    Radiology. 2022 Jul 19:212163. doi: 10.1148/radiol.212163.
    PubMed     Abstract available
    
    
    May 2022
33. JADVAR H
    Prostate-specific Membrane Antigen PET: Standard Imaging in Prostate Cancer.
    Radiology. 2022 May 24:221074. doi: 10.1148/radiol.221074.
    PubMed    
    
    
    
34. BASSO DIAS A, Finelli A, Bauman G, Veit-Haibach P, et al
    Impact of (18)F-DCFPyL PET on Staging and Treatment of Unfavorable Intermediate or High-Risk Prostate Cancer.
    Radiology. 2022 May 24:211836. doi: 10.1148/radiol.211836.
    PubMed     Abstract available
    
    
    
35. HAIDER MA
    It's Time for a Standardized MRI Assessment Scheme for Prostate Cancer Recurrence.
    Radiology. 2022 May 10:220701. doi: 10.1148/radiol.220701.
    PubMed    
    
    
    
36. PECORARO M, Turkbey BI, Purysko AS, Girometti R, et al
    Diagnostic Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence Reporting Assessment Score.
    Radiology. 2022 May 10:212252. doi: 10.1148/radiol.212252.
    PubMed     Abstract available
    
    
    March 2022
37. WU D, Jiang K, Li H, Zhang Z, et al
    Time-Dependent Diffusion MRI for Quantitative Microstructural Mapping of Prostate Cancer.
    Radiology. 2022 Mar 8:211180. doi: 10.1148/radiol.211180.
    PubMed     Abstract available
    
    
    
38. CHATTERJEE A, Oto A
    Prostate Tissue Microstructural Estimates Using Time-Dependent Diffusion MRI.
    Radiology. 2022 Mar 8:220056. doi: 10.1148/radiol.220056.
    PubMed    
    
    
    February 2022
39. KUMAR R, Singh SK, Mittal BR, Vadi SK, et al
    Safety and Diagnostic Yield of (68)Ga Prostate-specific Membrane Antigen PET/CT Guided Robotic-assisted Transgluteal Prostatic Biopsy.
    Radiology. 2022 Feb 22:204066. doi: 10.1148/radiol.204066.
    PubMed     Abstract available
    
    
    
40. UEDA T, Ohno Y, Yamamoto K, Murayama K, et al
    Deep Learning Reconstruction of Diffusion-weighted MRI Improves Image Quality for Prostatic Imaging.
    Radiology. 2022 Feb 1:204097. doi: 10.1148/radiol.204097.
    PubMed     Abstract available
    
    
    January 2022
41. CIVELEK AC
    Management of Metastatic Prostate Cancer Biochemical Recurrence with Use of (18)F-DCFPyL PET/CT.
    Radiology. 2022 Jan 25:212993. doi: 10.1148/radiol.212993.
    PubMed    
    
    
    
42. METSER U, Zukotynski K, Mak V, Langer D, et al
    Effect of (18)F-DCFPyL PET/CT on the Management of Patients with Recurrent Prostate Cancer: Results of a Prospective Multicenter Registry Trial.
    Radiology. 2022 Jan 25:211824. doi: 10.1148/radiol.211824.
    PubMed     Abstract available
    
    
    
43. RANASINGHE WKB, Troncoso P, Surasi DS, Ibarra Rovira JJ, et al
    Defining Diagnostic Criteria for Prostatic Ductal Adenocarcinoma at Multiparametric MRI.
    Radiology. 2022 Jan 25:204732. doi: 10.1148/radiol.204732.
    PubMed     Abstract available
    
    
    
44. LAMBERG H, Shankar PR, Singh K, Caoili EM, et al
    Preoperative Prostate MRI Predictors of Urinary Continence Following Radical Prostatectomy.
    Radiology. 2022 Jan 18:210500. doi: 10.1148/radiol.210500.
    PubMed     Abstract available
    
    
    
45. KANAS AF, Fenelon SS, Santos JMMM, Coelho RF, et al
    Case 297: Mucinous Adenocarcinoma of the Prostate.
    Radiology. 2022;302:238-242.
    PubMed     Abstract available
    
    
    December 2021
46. GOTTLIEB RH
    Introducing a Standard in Prostate Cancer Imaging Evaluation.
    Radiology. 2021 Dec 21:212111. doi: 10.1148/radiol.212111.
    PubMed    
    
    
    
47. WIBMER AG, Nikolovski I, Chaim J, Lakhman Y, et al
    Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes.
    Radiology. 2021 Dec 21:210875. doi: 10.1148/radiol.210875.
    PubMed     Abstract available
    
    
    November 2021
48. CHATTERJEE A, Mercado C, Bourne RM, Yousuf A, et al
    Validation of Prostate Tissue Composition by Using Hybrid Multidimensional MRI: Correlation with Histologic Findings.
    Radiology. 2021 Nov 9:204459. doi: 10.1148/radiol.2021204459.
    PubMed     Abstract available
    
    
    
49. WILLIAMS HT, Estes TL
    Anatomic and Functional Prostate Cancer Imaging.
    Radiology. 2021;301:E418.
    PubMed    
    
    
    October 2021
50. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
    Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Radiology. 2021;301:E380.
    PubMed    
    
    
    August 2021
51. WILLIAMS HT, Estes TL
    Anatomic and Functional Prostate Cancer Imaging.
    Radiology. 2021 Aug 31:211837. doi: 10.1148/radiol.2021211837.
    PubMed    
    
    
    
52. MARGEL D, Bernstine H, Groshar D, Ber Y, et al
    Diagnostic Performance of (68)Ga Prostate-specific Membrane Antigen PET/MRI Compared with Multiparametric MRI for Detecting Clinically Significant Prostate Cancer.
    Radiology. 2021 Aug 31:204093. doi: 10.1148/radiol.2021204093.
    PubMed     Abstract available
    
    
    July 2021
53. KANG SK, Mali RD, Prabhu V, Ferket BS, et al
    Active Surveillance Strategies for Low-Grade Prostate Cancer: Comparative Benefits and Cost-effectiveness.
    Radiology. 2021 Jul 13:204321. doi: 10.1148/radiol.2021204321.
    PubMed     Abstract available
    
    
    May 2021
54. DENIFFEL D, Healy GM, Dong X, Ghai S, et al
    Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.
    Radiology. 2021 May 25:204112. doi: 10.1148/radiol.2021204112.
    PubMed     Abstract available
    
    
    
55. LI M, Guo J, Hu P, Jiang H, et al
    Tomoelastography Based on Multifrequency MR Elastography for Prostate Cancer Detection: Comparison with Multiparametric MRI.
    Radiology. 2021;299:E259.
    PubMed    
    
    
    
56. GHAI S, Finelli A, Corr K, Chan R, et al
    MRI-guided Focused Ultrasound Ablation for Localized Intermediate-Risk Prostate Cancer: Early Results of a Phase II Trial.
    Radiology. 2021;299:E258.
    PubMed    
    
    
    
57. GOLDBERG SN
    More Interventional Oncologic Fire from COLDFIRE-2.
    Radiology. 2021;299:481-482.
    PubMed    
    
    
    April 2021
58. HARMON SA, Gesztes W, Young D, Mehralivand S, et al
    Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.
    Radiology. 2021 Apr 13:202425. doi: 10.1148/radiol.2021202425.
    PubMed     Abstract available
    
    
    
59. COSTA DN
    Multiparametric MRI of the Prostate: Beyond Cancer Detection and Staging.
    Radiology. 2021 Apr 13:204506. doi: 10.1148/radiol.2021204506.
    PubMed    
    
    
    February 2021
60. TEMPANY-AFDHAL CMC, Padhani A, Barentsz J, Weinreb J, et al
    Perspectives and Concerns about PI-RADS and Variability.
    Radiology. 2021;298:E112.
    PubMed    
    
    
    November 2020
61. BAZARGANI S, Bandyk M, Balaji KC
    Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: What about the Negatives?
    Radiology. 2020 Nov 3:202870. doi: 10.1148/radiol.2020202870.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.